Latest News & Updates
Breaking News
2 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Canada's Second Generic Semaglutide Clears Via CDMO Partnership
OneSource Specialty Pharma enables Canada's second generic semaglutide approval, highlighting CDMOs as critical gatekeepers in the GLP-1 generics race.
Pharma Now Editorial Team
AstraZeneca's Dublin API Plant Signals Regional Supply Shift
AstraZeneca opens a $360M Dublin API facility, signaling regional supply diversification amid U.S. tariff pressure.
Pharma Now Editorial Team
Gufic Biosciences Extends Oncology Reach via Selvax Investment
Gufic Biosciences increases its stake in Australian immunotherapy firm Selvax, founded 1987, targeting human and veterinary oncology.
Pharma Now Editorial Team
OpenAI Bets on Specialized AI With GPT-Rosalind, Built for Biochemistry and Genomics Reasoning
GPT-Rosalind marks OpenAI's shift to domain-specific AI, using advanced reasoning to accelerate drug discovery, genomics research, and early-stage scientific workflows in life sciences.
Mrudula Kulkarni
